Arthroscopic Surgical Procedures vs Sham Surgery for Patients With Femoroacetabular Impingement and/or Labral Tears.
HIPARTI
2 other identifiers
interventional
140
2 countries
2
Brief Summary
The primary aim of this study is to determine the efficacy of hip arthroscopic surgery compared to a sham surgery (diagnostic arthroscopy only) for patients with symptomatic and radiological findings related to impingement (FAI) and/or labral tears using a randomized controlled design (HIPARTI Study: Primary aim and the main paper: primary end point: iHOT 1 year follow-up)). Our main hypothesis is that surgical procedures of the hip will demonstrate greater efficacy than sham surgery (diagnostic hip arthroscopy only) for hip related quality of life (iHOT-33) after 1 year and at further (HIPARTI Study). The secondary aim of this study is to establish modifiable risk factors associated with pain, function, work participation and quality of life over 1 year in people aged 18-50 years with hip impingement and/or labral tears diagnosed at hip arthroscopy. (HARP Study: A separate paper will be published with this main aim for the HARP Study) Long-term follow-ups for HIPARTI Study as well as HARP Study will be performed at 2, 5 and 10 years (secondary aims and separate papers).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable surgery
Started Feb 2016
Longer than P75 for not_applicable surgery
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2016
CompletedFirst Submitted
Initial submission to the registry
February 15, 2016
CompletedFirst Posted
Study publicly available on registry
February 26, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2035
ExpectedMarch 25, 2025
May 1, 2024
8.3 years
February 15, 2016
March 21, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
International Hip Outcome Tool (IHOT-33)
Patient-reported outcome measure (PRO)
Baseline, 6,12 an 24 months follow-ups - 1 year follow-up is main outcome
Secondary Outcomes (11)
Expectations of surgery
Baseline
HOOS - Hip Dysfunction and Osteoarthritis Outcome Score
Baseline, 6,12 an 24 months follow-ups - only in some study sites
ASES Arthritis Self-Efficacy Scale
Baseline, 6,12 an 24 months follow-ups
Tampa scale of Kinesiophobia
Baseline, 6,12 an 24 months follow-ups
Hip Sports Activity Scale (HSAS)
Baseline, 6,12 an 24 months follow-ups
- +6 more secondary outcomes
Study Arms (3)
Hip arthroscopy surgical procedures (HIPARTI Study)
ACTIVE COMPARATORSurgery is performed under general anaesthesia. Traction and joint access is controlled by fluoroscopy. A diagnostic round in the central and peripheral compartment is performed. Labrum, cartilage, and other possible conditions are looked for and findings are documented. Any labral, chondral and bony pathology (cam or pincer) is treated. Labrum may be debrided, sutured, detached and refixed if needed to treat a pincer lesion. Labrum is secured with suture anchors. Pincer and cam resection is performed using an arthroscopic burr. Cartilage lesions maybe left untreated or treated with debridement or microfracture.
Sham surgery (HIPARTI Study)
PLACEBO COMPARATORThe same arthroscopic procedures as stated above are preformed, but no surgical interventions related to Cam, Pincer, or labral tear are performed, only diagnostic round in the central and peripheral compartment is performed. Labrum, cartilage, and other possible conditions are looked for and findings are documented.
Prospective Cohort (HARP Study)
ACTIVE COMPARATORThose that are not willing to be included in the RCT (HIPARTI Study), will be asked if they are willing to be included in the prospective cohort, or ongoing in countries were ONLY the surgery is performed (Australia). They will sign an informed concent and will undergo surgical interventions as part of usual care. Outcomes collected and follow-ups will be the same as for the RCT (HIPARTI).
Interventions
See arm/group description of Arthroscopic surgery and sham surgery (HIPARTI). HARP: only arthroscopic surgery
Eligibility Criteria
You may qualify if:
- hip pain during daily and/or spor t ing activities;
- intra-articular hip pain with radiological signs of FAI and/or labral tears eligible for hip arthroscopy (to be determined in a pragmatic fashion by the surgeon based on clinical examination and imaging
- the patient is able to give written informed consent and to participate fully in the interventions and follow-up procedures
You may not qualify if:
- pain that is not confirmed by physical examination of the hip
- evidence of preexisting osteoarthritis, defined as Tonnis grade \>1, or less than 3mm superior joint space width on AP pelvic radiograph
- center edge angle on radiograph \<25°; (v) previous known hip pathology such as Perthes' disease, slipped upper femoral epiphysis or avascular necrosis
- previous hip injury such as acetabular fracture, hip dislocation or femoral neck fracture
- previous hip surgery
- medical conditions complicating surgery (ASA 3); (ix) inflammatory joint disease (RA, Bechterew etc)
- physical inability to undertake testing procedures
- expected lack of compliance such as cognitive impairment, drug abuse or similar;
- inability to understand the written and spoken language of the treatment centre;
- contra-indications to placebo surgery, which will include large loose body, chondral flap \>1cm2 detached at 3 sides, complete labral radial flap tear and labral bucket-handle tear with complete avulsion \>1.5cm long
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Oslo University Hospitallead
- La Trobe Universitycollaborator
- University of Aarhuscollaborator
- Lund Universitycollaborator
- University of Oxfordcollaborator
- University of Ottawacollaborator
Study Sites (2)
LaTrobe University, School Allied Health, College of Science, Helath and Engineering
Melbourne, Victoria, 3086, Australia
Division of Orthopedic Surgery, Oslo University Hospital
Oslo, 4956, Norway
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
May Arna Risberg, PT, PhD
Oslo University Hospital
- STUDY DIRECTOR
Lars Nordsletten, MD, PhD
Oslo University Hospital
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- This is only for the RCT Study - the double-blinded study. The HARP study consists of only a prospective longitudinal study With same outcome measure and follow-ups; hence, given 3 arms. The below "Allocation" and "Number of Subjects" is ONLY for the RCT part of the study
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
February 15, 2016
First Posted
February 26, 2016
Study Start
February 1, 2016
Primary Completion
May 1, 2024
Study Completion (Estimated)
December 1, 2035
Last Updated
March 25, 2025
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share
Data will be shared across the sites participating in the HIPARTI and the HARP Study, according to the protocol and the decisions made by the Advisory Committee